Bulls holding strong on VITROMXSTO:VITR
Despite several attemps from the bears to reach the 160 level, the bulls are stronly in control.
It got cheap in the process. Probably a good opportunity.
Risk 15%
Next report date
Report period
Q2 2024
EPS estimate
1.09SEK
Revenue estimate
919.22 MSEK
−28.3SEK
−3.85 BSEK
3.51 BSEK
69.04 M
About VITROLIFE AB
Sector
Industry
CEO
Bronwyn Brophy
Website
Headquarters
Gothenburg
Employees (FY)
1.12 K
Founded
1989
FIGI
BBG00L333KN0
Vitrolife AB engages in the development, manufacture, and sale of products and systems for the preparation, cultivation, and storage of human cells, tissue, and organs. Its products and services include oocyte retrieval needles, sperm processing, IVF media and oil, micromanipulation pipettes, labware, benchtop incubators, time-lapse systems, preimplantation genetic testing, cryopreservation, laser and imaging systems, and lab quality control systems. The firm operates through the following geographical segments: Europe, Middle East, and Africa (EMEA); North and South America; Japan and Pacific; and Asia. The company was founded in 1994 and is headquartered in Gothenburg, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 0YAY is 163.5 SEK — it has increased by 3.12% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSIN exchange VITROLIFE AB NPV stocks are traded under the ticker 0YAY.
VITROLIFE AB NPV is going to release the next earnings report on Jul 17, 2024. Keep track of upcoming events with our Earnings Calendar.
0YAY stock is 3.11% volatile and has beta coefficient of 1.41. Check out the list of the most volatile stocks — is VITROLIFE AB NPV there?
0YAY earnings for the last quarter are −30.86 SEK per share, whereas the estimation was 0.90 SEK resulting in a −3.55 K% surprise. The estimated earnings for the next quarter are 0.93 SEK per share. See more details about VITROLIFE AB NPV earnings.
VITROLIFE AB NPV revenue for the last quarter amounts to 904.00 M SEK despite the estimated figure of 904.00 M SEK. In the next quarter revenue is expected to reach 874.72 M SEK.
Yes, you can track VITROLIFE AB NPV financials in yearly and quarterly reports right on TradingView.
0YAY stock has fallen by 1.77% compared to the previous week, the month change is a 17.78% fall, over the last year VITROLIFE AB NPV has showed a 27.29% decrease.
0YAY net income for the last quarter is 115.00 M SEK, while the quarter before that showed −4.18 B SEK of net income which accounts for 102.75% change. Track more VITROLIFE AB NPV financial stats to get the full picture.
Today VITROLIFE AB NPV has the market capitalization of 22.11 B, it has decreased by 13.13% over the last week.
Yes, 0YAY dividends are paid annually. The last dividend per share was 1.00 SEK. As of today, Dividend Yield (TTM)% is 0.52%. Tracking VITROLIFE AB NPV dividends might help you take more informed decisions.
Like other stocks, 0YAY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VITROLIFE AB NPV stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 27, 2024, the company has 1.12 K employees. See our rating of the largest employees — is VITROLIFE AB NPV on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VITROLIFE AB NPV technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VITROLIFE AB NPV stock shows the sell signal. See more of VITROLIFE AB NPV technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on VITROLIFE AB NPV future price: according to them, 0YAY price has a max estimate of 265.00 SEK and a min estimate of 210.00 SEK. Read a more detailed VITROLIFE AB NPV forecast: see what analysts think of VITROLIFE AB NPV and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VITROLIFE AB NPV EBITDA is 1.16 B SEK, and current EBITDA margin is 32.97%. See more stats in VITROLIFE AB NPV financial statements.